124 related articles for article (PubMed ID: 19864122)
41. An association between niacin skin flush response and plasma triglyceride levels in patients with schizophrenia.
Nadalin S; Jonovska S; Šendula Jengić V; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2020 Apr; 155():102084. PubMed ID: 32126479
[TBL] [Abstract][Full Text] [Related]
42. Niacin skin flushing in schizophrenic and depressed patients and healthy controls.
Bosveld-van Haandel L; Knegtering R; Kluiter H; van den Bosch RJ
Psychiatry Res; 2006 Aug; 143(2-3):303-6. PubMed ID: 16837062
[TBL] [Abstract][Full Text] [Related]
43. Niacin skin flush in schizophrenia: a preliminary report.
Ward PE; Sutherland J; Glen EM; Glen AI
Schizophr Res; 1998 Feb; 29(3):269-74. PubMed ID: 9516668
[TBL] [Abstract][Full Text] [Related]
44. The interaction of electrodermal activity and expressed emotion in predicting symptoms in recent-onset schizophrenia.
Subotnik KL; Schell AM; Chilingar MS; Dawson ME; Ventura J; Kelly KA; Hellemann GS; Nuechterlein KH
Psychophysiology; 2012 Aug; 49(8):1035-8. PubMed ID: 22680838
[TBL] [Abstract][Full Text] [Related]
45. Electrodermal responding and chlorpromazine treatment in schizophrenia.
Yannitsi S; Liakos A; Papakostas Y
Br J Psychiatry; 1987 Jun; 150():850-3. PubMed ID: 3651739
[TBL] [Abstract][Full Text] [Related]
46. Electrodermal activity at acupuncture points differentiates patients with current pain from pain-free controls.
Turner L; Linden W; Marshall C
Appl Psychophysiol Biofeedback; 2013 Mar; 38(1):71-80. PubMed ID: 23322071
[TBL] [Abstract][Full Text] [Related]
47. Electrodermal anomalies in recent-onset schizophrenia: relationships to symptoms and prognosis.
Dawson ME; Nuechterlein KH; Schell AM
Schizophr Bull; 1992; 18(2):295-311. PubMed ID: 1621075
[TBL] [Abstract][Full Text] [Related]
48. Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.
Smesny S; Berger G; Rosburg T; Riemann S; Riehemann S; McGorry P; Sauer H
J Psychiatr Res; 2003; 37(3):237-47. PubMed ID: 12650743
[TBL] [Abstract][Full Text] [Related]
49. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia.
Puri BK; Hirsch SR; Easton T; Richardson AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):49-52. PubMed ID: 11853118
[TBL] [Abstract][Full Text] [Related]
50. Electrodermal non-responding in schizophrenia: relationships to attentional, clinical, biochemical, computed tomographical and genetic factors.
Alm T; Lindström LH; Ost LG; Ohman A
Int J Psychophysiol; 1984 Feb; 1(2):195-208. PubMed ID: 6542079
[TBL] [Abstract][Full Text] [Related]
51. The niacin challenge test in schizophrenia: past, present and future.
Lin A; Hudson CJ
Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):17-9. PubMed ID: 8888118
[TBL] [Abstract][Full Text] [Related]
52. Electrodermically nonresponsive schizophrenia patients make more errors in the Stroop Color Word Test, indicating selective attention deficit.
Lopes-Machado EZ; Crippa JA; Hallak JE; Guimarães FS; Zuardi AW
Schizophr Bull; 2002; 28(3):459-66. PubMed ID: 12645677
[TBL] [Abstract][Full Text] [Related]
53. Electrodermal activity in the 1980s: a review.
Christie MJ
J R Soc Med; 1981 Aug; 74(8):616-22. PubMed ID: 7288800
[No Abstract] [Full Text] [Related]
54. Electrodermal activity and clinical status in chronic schizophrenia.
Katsanis J; Iacono WG
J Abnorm Psychol; 1994 Nov; 103(4):777-83. PubMed ID: 7822580
[TBL] [Abstract][Full Text] [Related]
55. Psychophysiological studies in schizophrenic patients selected on the basis of a "genetic marker".
Maricq HR; Weinrich MC
Acta Psychiatr Scand; 1980 Mar; 61(3):185-208. PubMed ID: 6929648
[TBL] [Abstract][Full Text] [Related]
56. Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics.
Fiedler P; Wolkin A; Rotrosen J
Biol Psychiatry; 1986 Nov; 21(13):1347-50. PubMed ID: 3756281
[No Abstract] [Full Text] [Related]
57. Electrodermal orienting response, maternal age, and season of birth in schizophrenia.
Ohlund LS; Ohman A; Ost LG; Lindström LH; Wieselgren IM
Psychiatry Res; 1991 Feb; 36(2):223-32. PubMed ID: 2017536
[TBL] [Abstract][Full Text] [Related]
58. Recent studies of psychophysiology in schizophrenia.
Spohn HE; Patterson T
Schizophr Bull; 1979; 5(4):581-611. PubMed ID: 42141
[TBL] [Abstract][Full Text] [Related]
59. Physiologic and symptomatic responses to low-level substances in individuals with and without chemical sensitivities: a randomized controlled blinded pilot booth study.
Joffres MR; Sampalli T; Fox RA
Environ Health Perspect; 2005 Sep; 113(9):1178-83. PubMed ID: 16140624
[TBL] [Abstract][Full Text] [Related]
60. Electrodermal and heart-rate measurements in chronic and partially remitted schizophrenic patients.
Tarrier N; Cooke EC; Lader MH
Acta Psychiatr Scand; 1978 May; 57(5):369-76. PubMed ID: 676780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
